论文部分内容阅读
我们近一年多对160例经临床证实的恶性肿瘤患者同时进行了癌胚抗原(Carcino-Embryonic Antigen 以下简称 CEA)和血清铁蛋白(Serum Ferrum 以下简称 SF)检测,其中30例还进行了体外血柱形成和血小板粘附率测定。结果表明,这些检测均有一定的临床应用价值,现报告如下。
Over the past year, we have conducted 160 concurrent clinically proven cancer patients with Carcino-Embryonic Antigen (CEA) and Serum Ferrum (SF), of which 30 were also performed in vitro. Blood column formation and platelet adhesion rate determination. The results show that these tests have a certain clinical application value, the report is as follows.